N-acetyltransferase 2 and CYP2E1 polymorphisms do not increase the risk of antituberculosis drug-induced hepatotoxicity in caucasian population Source: Annual Congress 2008 - Epidemiological and clinical aspects of tuberculosis control Year: 2008
Association of xenobiotic metabolizing gene polymorphisms and chronic obstructive pulmonary disease in Indian population Source: Annual Congress 2012 - COPD inflammation and genes Year: 2012
Genetic polymorphisms of the adrenergic ß2-receptor in COPD: systematic review and meta-analyses of disease risk and treatment response Source: International Congress 2017 – Rare and common genetic variants of common and rare airway diseases Year: 2017
‘Drug‘-induced interstitial lung disease in a patient with a heterozygote P450 polymorphism Source: Eur Respir J 2007; 30: Suppl. 51, 118s Year: 2007
Detoxifying enzymes genes (EPHX1, CYP1A1 and GSTP1) genotypes and risk of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: Suppl. 45, 196s Year: 2003
Genome-wide association analysis reveals 12q13.3–q14.1 as new risk locus for sarcoidosis Source: Eur Respir J 2013; 41: 888-900 Year: 2013
Association of polymorphism of NAT2 gene and group factors of blood (ABO, MN, Gm) with risk of COPD Source: Eur Respir J 2004; 24: Suppl. 48, 60s Year: 2004
CYP1A1 polymorphisms and risk of lung cancer in a Brazilian populationSource: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
Frequency, severity and risk factors of drug-induced liver injury during treatment of new tuberculosis patients Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012
Metabolic gene polymorphisms (CYP1A1, EPHX1, GSTM1 and GSTP1) associations with the severity of cystic fibfosis airway disease Source: Eur Respir J 2003; 22: Suppl. 45, 173s Year: 2003
Study about the association of genetic polymorphism of glutathione S-transferases and susceptibility to chronic obstructive pulmonary disease Source: Eur Respir J 2005; 26: Suppl. 49, 53s Year: 2005
Association of NRAMP1 gene polymorphisms with COPD clinical signs Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007
Association of NRAMP1 gene polymorphisms with COPD clinical signs Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond Year: 2018
Risk score of drug-induced liver injury among new tuberculosis patients Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria Year: 2018
NAT2 gene polymorphism in lung cancer: A study from north India Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012
P53 codon 72, GSST1, GSTM1 and CCR5del32 genetic polymorphism: Evidence of correlation between asthma and lung cancer Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015
Study on association between genetic polymorphism of glutathione S-transferase P1 and susceptibility of patients with chronic obstructive pulmonary disease of Han Nationality in China Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003
Genetic polymorphism of epoxide hydrolase and GSTM1 in lung cancer susceptibility Source: Eur Respir J 2002; 20: Suppl. 38, 229s Year: 2002
EPHX1 polymorphisms, COPD and asthma in 47,000 individuals and in meta-analysis Source: Eur Respir J 2011; 37: 18-25 Year: 2011
Association of GSTT1, GSTM1 and CYP1A1 MSP1 gene polymorphism with lung cancer patients in north Indian population Source: Annual Congress 2010 - Epidemiology of lung cancer Year: 2010